CIFRAN

This brand name is authorized in Australia, Lithuania, New Zealand, Nigeria, Romania, South Africa.

Active ingredients

The drug CIFRAN contains one active pharmaceutical ingredient (API):

1	Ciprofloxacin UNII 4BA73M5E37 - CIPROFLOXACIN HYDROCHLORIDE
	Ciprofloxacin is a fluoroquinolone antibacterial agent. The bactericidal action of ciprofloxacin results from the inhibition of both type II topoisomerase (DNA-gyrase) and topoisomerase IV, required for bacterial DNA replication, transcription, repair and recombination.
	Read more about Ciprofloxacin

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01MA02	Ciprofloxacin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01M Quinolone antibacterials → J01MA Fluoroquinolones
Discover more medicines within J01MA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	1209P
LT	Valstybinė vaistų kontrolės tarnyba	1004639
NG	Registered Drug Product Database	04-2613, 04-4673
Switch country to Nigeria in order to find specific presentations of CIFRAN
NZ	Medicines and Medical Devices Safety Authority	10755, 10756, 10757
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W65056001, W65057001
ZA	Health Products Regulatory Authority	33/20.1.1/0365, 33/20.1.1/0366